Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-blind, Randomized Placebo-controlled Clinical Trial to Investigate the Safety and Efficacy of Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

NCT05939167 is registered in ClinicalTrials.gov with Cell Energy Life Sciences Group Co. LTD as lead sponsor.

NCT NCT05939167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05939167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-blind, Randomized Placebo-controlled Clinical Trial to Investigate the Safety and Efficacy of Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage
Lead sponsor
Cell Energy Life Sciences Group Co. LTD
Phase
Phase 1/2
Overall status
Recruiting
Start date
December 10, 2023
Completion date
July 10, 2028
Enrollment
150 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aids